durvalumab,paclitaxel,carboplatin,cisplatin,gemcitabine,pemetrexed
astrazeneca
['durva', 'lung', 'aegean', 'imfinzi', 'astrazeneca']
astrazeneca presents p-iii trial (aegean) results of imfinzi (durvalumab) for resectable non-small cell lung cancer at aacr 2023 #clinicaltrials 
Real-time summarized News in 3 shots from pharma, biotech, medtech, digital health and life sciences industry readable in 60 seconds